Search

everythinglearnresearchcommunity

for

Search:↓

Hispanic/Latinx patients with alopecia areata often have it before age 40, with females and certain health conditions like rheumatoid arthritis more commonly affected.

People with Alopecia Areata are more likely to have autoimmune diseases, inflammatory diseases, and mental health issues like anxiety and depression.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Beard hair loss can signal early diabetes and thyroid issues, treatable with specific cream.

Treatments for autoimmune hair loss have limited success and often relapse, and emotional support is crucial for those affected.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

The document suggests there might be a link between Kawasaki Disease and Alopecia Areata that needs more research.

Treatments for autoimmune hair loss have limited success and patients need emotional support and self-acceptance.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

People with alopecia areata may have a higher risk of blood clots.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Long eyelashes in a patient were an unusual sign of systemic lupus erythematosus.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Trichoscopy helps diagnose and monitor alopecia areata by looking at a combination of specific hair and scalp features.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

New cytokine-targeted therapies show promise for treating alopecia areata.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.